PageOverview.com
 

Domains pointed to dns3.imc2.com

These websites are known to have been using dns3.imc2.com as their DNS nameserver.

 
Number of websites/domains displayed: 68
Results found: 68
 

Websites discovered:

shirecontent.com
http://pageoverview.com/website-report/shirecontent.com
  • Expected expiration: September 29th in 2017
  • Creation date: September 29th in 2009
  • Renew date: September 2nd in 2016
Shire : un innovateur mondial dans le domaine des produits biopharmaceutiques spécialisés
http://pageoverview.com/website-report/shire.fr
Notre but est d'aider les personnes souffrant d'une maladie qui altère leur qualité de vie à mieux vivre. Découvrez nos valeurs, notre vision et nos traitements novateurs sur le site shire.com.
  • Expected expiration: January 24th in 2018
  • Creation date: January 22nd in 2013
  • Renew date: January 24th in 2017
Fabry Disease | Fabry Awareness
http://pageoverview.com/website-report/fabryawareness.com
Healthcare practitioners: Learn about symptoms, signs, management, and other aspects of Fabry Disease and help us raise awareness of this condition.
  • Expected expiration: July 26th in 2018
  • Creation date: July 26th in 2016
  • Renew date: June 29th in 2017
Information and Support for People with Primary Immune Deficiency
http://pageoverview.com/website-report/immunedisease.com
Learn about primary immune deficiency (PI), how it’s diagnosed, the types of PI, and the resources and support available.
  • Expected expiration: September 29th in 2018
  • Creation date: September 29th in 1999
  • Renew date: September 25th in 2017
  • Google Analytics: 73609129-1
About Us | Baxalta
http://pageoverview.com/website-report/baxalta.co.uk
Learn about Baxalta’s values, company leadership, and our passion for improving patient care.
  • Expected expiration: September 10th in 2018
  • Creation date: September 10th in 2014
  • Renew date: September 6th in 2017
CINRYZE® (C1 esterase inhibitor [human])
http://pageoverview.com/website-report/cinryze.com
  • Expected expiration: April 3rd in 2018
  • Creation date: April 3rd in 2007
  • Renew date: March 8th in 2017
Official Site: MYDAYIS® (mixed salts of a single-entity amphetamine product)
http://pageoverview.com/website-report/mydayis.com
Learn about Mydayis, used in the treatment of ADHD in patients 13 years and older. See Safety Info & Abuse Warning. Not for use in ages 12 & younger.
  • Expected expiration: May 28th in 2018
  • Creation date: May 28th in 2014
  • Renew date: May 2nd in 2017
American Diabetes Association®
http://pageoverview.com/website-report/diabetesarchive.net
Our Mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.
  • Expected expiration: October 23rd in 2019
  • Creation date: October 23rd in 2009
  • Renew date: October 2nd in 2014
  • Google Analytics: 2200333-63
Stop Diabetes Homepage: Stop Diabetes® American Diabetes Association
http://pageoverview.com/website-report/stopdiabetes.com
  • Expected expiration: November 11th in 2021
  • Creation date: November 11th in 2003
  • Renew date: September 6th in 2016
  • Google Analytics: 2200333-63
血友病の情報サイト「ヘモフィリアステーション」
http://pageoverview.com/website-report/hemophilia-st.jp
血友病の情報サイト「ヘモフィリアステーション」は血友病の基礎知識や症状等をわかりやすく紹介したページや治療等の最新情報、患者さんやご家族へのインタビュー・体験談を掲載しています
  • Expected expiration: April 30th in 2018
  • Creation date: April 6th in 2012
  • Renew date: May 3rd in 2017
  • Google Analytics: 30904668-1
ADHD & You is Dedicated to Helping You
http://pageoverview.com/website-report/keepmomming.com
Whether you have ADHD or you care for someone that does, ADHD & You is dedicated to supporting you with tips, resources, and more.
  • Expected expiration: October 23rd in 2017
  • Creation date: October 23rd in 2013
  • Renew date: September 26th in 2016
Welcome to MODsocket | MODsocket
http://pageoverview.com/website-report/modsocket.com
  • Expected expiration: April 9th in 2018
  • Creation date: April 9th in 2008
  • Renew date: April 10th in 2017
  • Google Analytics: 23631818-1
Shire|夏尔中国官网
http://pageoverview.com/website-report/shire.com.cn
Shire|夏尔中国官网:夏尔是专业为罕见病及其他专科疾病患者服务的全球领先生物科技公司,夏尔全球24000名员工长期致力于研发并提供突破性创新疗法,为患者提供终身受益的帮助以获得更加美好的生活。
  • Creation date: May 28th in 2005
  • Expected expiration: June 28th in 2018
  • Google Plus Account: 116858740385185632622
Binge Eating Disorder Facts and Information
http://pageoverview.com/website-report/bingeeatingdisorder.com
Binge eating disorder (B.E.D.) runs deeper than food. Talk to a doctor about symptoms and treatment options including therapy and nutritional counseling.
  • Expected expiration: September 28th in 2018
  • Creation date: September 28th in 2004
  • Renew date: July 30th in 2014
Could I Have ADHD? | ADHDAdulthood.com
http://pageoverview.com/website-report/adhdadulthood.com
Approximately 10.5 million US adults are estimated to have ADHD. Read more about ADHD symptoms, causes and treatment options here.
  • Expected expiration: January 20th in 2018
  • Creation date: January 20th in 2016
  • Renew date: December 29th in 2016
Shire: líder global em biotecnologia focada em doenças raras
http://pageoverview.com/website-report/shire.com.br
Na Shire, possibilitamos uma vida melhor às pessoas com condições que afetam sua maneira de viver.
  • Expected expiration: October 21st in 2017
  • Creation date: October 21st in 2007
  • Renew date: September 21st in 2016
Shire: Leader Mondiale Nella Specialità Biopharmaceuticals
http://pageoverview.com/website-report/shireitalia.it
Il nostro scopo è quello di consentire alle persone con condizioni di vita che alterano a condurre una vita migliore. Scopri i nostri terapie d'avanguardia, visione e valori a shire.com.
  • Expected expiration: March 14th in 2018
  • Creation date: December 13th in 2004
  • Renew date: March 30th in 2017
Shire: A Global Innovator in Specialty Biopharmaceuticals
http://pageoverview.com/website-report/shire.de
Our purpose is to enable people with life-altering conditions to lead better lives. Explore our pioneering therapies, vision, and values at shire.com.
  • Renew date: July 31st in 2015
Treatment: ADHD & Moderate to Severe B.E.D. in Adults
http://pageoverview.com/website-report/vyvanse.com
Find information on Vyvanse® (lisdexamfetamine dimesylate). Not for weight loss. See Important Safety Info & Warning About Abuse and Dependence.
  • Expected expiration: October 24th in 2017
  • Creation date: October 24th in 2006
  • Renew date: September 27th in 2016
Registration
http://pageoverview.com/website-report/vyvansesavings.com
  • Expected expiration: June 18th in 2017
  • Creation date: June 18th in 2010
  • Renew date: May 22nd in 2016
Home | Shire 2017 ADHD Scholarship Program
http://pageoverview.com/website-report/shireadhdscholarship.com
  • Expected expiration: April 19th in 2018
  • Creation date: April 19th in 2011
  • Renew date: March 23rd in 2017
  • Google Analytics: 26122091-1
ゴーシェテラス|gaucherterrace.jp
http://pageoverview.com/website-report/gaucherterrace.jp
ゴーシェ病患者さんとご家族のための専門サイト
  • Expected expiration: June 30th in 2018
  • Creation date: June 25th in 2015
  • Renew date: July 1st in 2017
GATTEX® (teduglutide [rDNA origin]) for Injection
http://pageoverview.com/website-report/gattex.com
GATTEX® is a prescription medicine for adults with Short Bowel Syndrome who need additional nutrition or fluids from IV feeding. See Serious Side Effects.
  • Expected expiration: January 13th in 2021
  • Creation date: January 13th in 2005
  • Renew date: May 29th in 2016
Official HCP Site: MYDAYIS® (mixed salts of a single-entity amphetamine product)
http://pageoverview.com/website-report/mydayis-pro.com
  • Expected expiration: July 20th in 2018
  • Creation date: July 20th in 2017
  • Renew date: July 25th in 2017
ONCASPAR® (pegaspargase)
http://pageoverview.com/website-report/oncaspar.com
ONCASPAR (pegaspargase) is given to patients with acute lymphoblastic leukemia (ALL) as part of a group of chemotherapy medications. ONCASPAR works by starving leukemia cells of the nutrients they need to thrive.
  • Expected expiration: October 21st in 2020
  • Creation date: October 21st in 2008
  • Renew date: September 13th in 2016
  • Google Analytics: 73262557-1
Your Resource for ADHD in Children: ADHDchildhood.com
http://pageoverview.com/website-report/adhdandyou.com
Learn about childhood attention deficit hyperactivity disorder (ADHD). Find, causes, symptoms, treatment tips and other valuable information.
  • Expected expiration: August 23rd in 2017
  • Creation date: August 23rd in 2005
  • Renew date: July 27th in 2016
Xiidra® (lifitegrast ophthalmic solution) 5% for Dry Eye Disease
http://pageoverview.com/website-report/xiidra.com
Discover Xiidra ®, used for the treatment of the signs and symptoms of dry eye disease. Most common side effects include eye irritation, discomfort or blurred vision when drops are applied to the eyes, and an unusual taste sensation.
  • Expected expiration: August 26th in 2017
  • Creation date: August 26th in 2013
  • Renew date: July 30th in 2016
Shire Hematology Support| Hematology Resources & Copay Assistance
http://pageoverview.com/website-report/hematologysupport.com
Living with hemophilia or von Willebrand disease? Explore Shire Hematology Support to learn about treatment trial programs and copay assistance.
  • Expected expiration: July 8th in 2018
  • Creation date: July 8th in 2015
  • Renew date: July 4th in 2017
Concerned About ADHD symptoms?
http://pageoverview.com/website-report/vyvanseadult.com
What are ADHD symptoms? Do ADHD symptoms differ by settings? Talk to your doctor. See Important Safety Information & Warning about Abuse and Dependence.
  • Expected expiration: December 19th in 2017
  • Creation date: December 19th in 2007
  • Renew date: November 22nd in 2016
What is Hunter Syndrome? - Learn More at HunterSyndrome.info
http://pageoverview.com/website-report/huntersyndrome.info
Hunter Syndrome (MPS II) is a serious genetic disorder that primarily affects males. People with MPS II lack an enzyme that breaks down mucopolysaccharides.
  • Expected expiration: April 12th in 2019
  • Creation date: April 12th in 2013
  • Renew date: November 17th in 2017
Eu Foco
http://pageoverview.com/website-report/eufoco.com.br
This site is for anyone who might be affected by ADHD or who cares for someone who does. Remember, you are not alone and here you will find what living ADHD looks like by understanding what ADHD is, what its symptoms are, and how it is diagnosed.
  • Expected expiration: February 28th in 2019
  • Creation date: February 28th in 2016
  • Renew date: January 29th in 2018
  • Google Analytics: 72439429-3
Official Site for ADVATE® [Antihemophilic Factor (Recombinant)]
http://pageoverview.com/website-report/advate.com
Learn about ADVATE. Please see the ADVATE Detailed Important Risk Information and full Prescribing Information.
  • Expected expiration: June 3rd in 2024
  • Creation date: June 3rd in 2002
  • Renew date: September 1st in 2016
Jennifer Aniston’s chronic dry eye story | it’s time for eyelove®
http://pageoverview.com/website-report/myeyelove.com
Hear about Jen’s Chronic Dry Eye story. Find out if it is time to chat with your Eye Doctor and get the scoop on Chronic Dry Eye.
  • Expected expiration: October 1st in 2017
  • Creation date: October 1st in 2015
  • Renew date: September 4th in 2016
Vyvanse® (lisdexamfetamine dimesylate) CII for moderate to severe B.E.D. in adults & ADHD
http://pageoverview.com/website-report/shireadhd.com
Information about a treatment for ADHD and moderate to severe binge eating disorder in adults. Limitation against use for weight loss. See Important Safety Info & Boxed Warning about Abuse and Dependence.
  • Expected expiration: June 20th in 2018
  • Creation date: June 20th in 2007
  • Renew date: May 24th in 2017
MEplusYOU Acquired by Moroch Partners | Moroch Partners
http://pageoverview.com/website-report/imc2.com
Moroch Partners has announced that it has acquired MEplusYOU.
  • Expected expiration: October 24th in 2017
  • Creation date: October 25th in 1996
  • Renew date: July 26th in 2016
Home - ADHD Institute
http://pageoverview.com/website-report/adhd-institute.com
  • Expected expiration: February 1st in 2018
  • Creation date: February 1st in 2011
  • Renew date: January 6th in 2017
  • Google Analytics: 27666271-1
Xiidra® (lifitegrast ophthalmic solution) 5% Official ECP Site
http://pageoverview.com/website-report/xiidra-ecp.com
Discover Xiidra® (lifitegrast ophthalmic solution) 5%, indicated to treat both the signs and symptoms of Dry Eye Disease. See Safety and Prescribing Info.
  • Expected expiration: May 13th in 2018
  • Creation date: May 13th in 2016
  • Renew date: April 16th in 2017
ホーム
http://pageoverview.com/website-report/shire.co.jp
  • Creation date: December 17th in 2012
  • Renew date: December 17th in 2012
Treatment: ADHD & Moderate to Severe B.E.D. in Adults
http://pageoverview.com/website-report/theydotherest.com
Find information on Vyvanse® (lisdexamfetamine dimesylate). Not for weight loss. See Important Safety Info & Warning About Abuse and Dependence.
  • Expected expiration: August 10th in 2017
  • Creation date: August 10th in 2011
  • Renew date: July 14th in 2016
VONVENDI® [von Willebrand factor (Recombinant)] Official Website: For Adults with von Willebrand disease (VWD)
http://pageoverview.com/website-report/vonvendi.com
Learn about VONVENDI for adults with VWD. Please see Detailed Important Risk Information and full Prescribing Information.
  • Expected expiration: February 6th in 2019
  • Creation date: February 6th in 2015
  • Renew date: February 2nd in 2018
Ulcerative Colitis (UC) Treatment | Lialda® (mesalamine)
http://pageoverview.com/website-report/lialda.com
Check out Lialda for induction of remission in active mild to moderate UC and maintenance of UC remission. Read safety info including potential kidney problems.
  • Expected expiration: June 20th in 2018
  • Creation date: June 20th in 2005
  • Renew date: May 24th in 2017
Shire Clinical Trials and Medical Research | ShireTrials.com
http://pageoverview.com/website-report/shiretrials.com
Learn about Shire clinical research studies. We are recruiting patients for clinical trials and research focused on ADHD, angioedema and other conditions.
  • Expected expiration: February 9th in 2019
  • Creation date: February 9th in 2006
  • Renew date: January 13th in 2018
Vyvanse® (lisdexamfetamine dimesylate) CII - HCP Site
http://pageoverview.com/website-report/vyvansepro.com
An ADHD and moderate to severe B.E.D in adults treatment. Limitation against use for weight loss. See Important Safety Info & Boxed Warning about Abuse and Dependence.
  • Expected expiration: April 21st in 2018
  • Creation date: April 21st in 2009
  • Renew date: March 25th in 2017
Treatment: ADHD & Moderate to Severe B.E.D. in Adults
http://pageoverview.com/website-report/udotherest.com
Find information on Vyvanse® (lisdexamfetamine dimesylate). Not for weight loss. See Important Safety Info & Warning About Abuse and Dependence.
  • Expected expiration: June 21st in 2017
  • Creation date: June 21st in 2011
  • Renew date: May 25th in 2016
PENTASA® (mesalamine) Official Web Site
http://pageoverview.com/website-report/pentasaus.com
  • Expected expiration: July 22nd in 2018
  • Creation date: July 22nd in 2003
  • Renew date: June 25th in 2017
ADYNOVATE® [Antihemophilic Factor (Recombinant), PEGylated] Official Site
http://pageoverview.com/website-report/adynovate.com
The official site for ADYNOVATE. Please see ADYNOVATE Detailed Important Risk Information and full Prescribing Information.
  • Expected expiration: March 10th in 2018
  • Creation date: March 10th in 2015
  • Renew date: March 6th in 2017
ADVATEPRO.COM
http://pageoverview.com/website-report/advatepro.com
The official ADVATE [Antihemophilic Factor (Recombinant)] site for U.S. healthcare professionals. See Detailed Important Risk Information and full Prescribing Information.
  • Expected expiration: March 13th in 2018
  • Creation date: March 13th in 2014
  • Renew date: March 9th in 2017
Shire - Profesionales
http://pageoverview.com/website-report/shireprofesionales.es
Web dirigida exclusivamente al Profesional Sanitario facultado para prescribir o dispensar medicamentos en España. Información especializada.
  • Google Analytics: 75755399-1
Apotheke im Freihof Brüttisellen - Willkommen
http://pageoverview.com/website-report/apo-imfreihof.ch
Arzneimittel & Gesundheit in der Apotheke im Freihof Brüttisellen
  • Google Analytics: 75999011-3
Willkommen bei den BioLife Plasmazentren
http://pageoverview.com/website-report/plasmazentrum.at
  • Google Analytics: 75999011-2
Vyvanse® (lisdexamfetamine dimesylate) Copay Information
http://pageoverview.com/website-report/vyvansecopay.com
Find your copay information. See Important Safety Info & Warning regarding Potential for Abuse and Dependence.
  • Expected expiration: November 8th in 2018
  • Creation date: November 8th in 2013
  • Renew date: October 12th in 2017
Treatment: ADHD & Moderate to Severe B.E.D. in Adults
http://pageoverview.com/website-report/shireregistration.com
Find information on Vyvanse® (lisdexamfetamine dimesylate). Not for weight loss. See Important Safety Info & Warning About Abuse and Dependence.
  • Expected expiration: December 11th in 2017
  • Creation date: December 11th in 2013
  • Renew date: November 17th in 2016
Technology Spa, we exist to provide peace of mind.
http://pageoverview.com/website-report/techspa.com
  • Expected expiration: October 9th in 2017
  • Creation date: October 9th in 2003
  • Renew date: November 6th in 2014
  • Google Analytics: 75439035-1
How Do you Respond to Adult ADHD? For Healthcare Professionals
http://pageoverview.com/website-report/qandadhd.com
Adult patients experience ADHD symptoms in multiple settings. Learn how medical professionals respond to their patients.
  • Expected expiration: March 9th in 2019
  • Creation date: March 9th in 2017
  • Renew date: February 10th in 2018
Home
http://pageoverview.com/website-report/adhs-zukunftstraeume.de
  • Renew date: July 8th in 2015
  • Google Analytics: 27662357-1
Haemophilia Care
http://pageoverview.com/website-report/haemophiliacare.co.uk
  • Expected expiration: November 6th in 2017
  • Creation date: November 6th in 2006
  • Renew date: June 15th in 2017
  • Google Analytics: 73268837-12
Shire: Shire ist das führende globale Biotechnologie Unternehmen im Bereich seltene Erkrankungen
http://pageoverview.com/website-report/shire.at
Shire ist das führende globale Biotechnologie Unternehmen im Bereich seltene Erkrankungen.
    Shire: Compañía biotecnológica líder mundial en enfermedades raras y patologías altamente especializadas
    http://pageoverview.com/website-report/shire.es
    Nuestro propósito es marcar la diferencia en la vida de aquellos que viven afectados por enfermedades raras y de alta especialización.
      CombiPatch: Hormone Therapy
      http://pageoverview.com/website-report/combipatch.com
      Learn about CombiPatch, a hormone therapy that combines estrogen and progestin in a twice-weekly patch.
      • Expected expiration: March 9th in 2019
      • Creation date: March 10th in 1998
      • Renew date: August 6th in 2014
      • Google Analytics: 17440704-1
      ADHD in Children
      http://pageoverview.com/website-report/vyvansekids.com
      Find information on ADHD in children (6-17). See Important Safety Information & Warning About Abuse and Dependence.
      • Expected expiration: December 19th in 2017
      • Creation date: December 19th in 2007
      • Renew date: November 22nd in 2016
      intuniv.com
      http://pageoverview.com/website-report/intuniv.com
      • Expected expiration: June 15th in 2017
      • Creation date: June 15th in 2002
      • Renew date: May 19th in 2016
      Mijn hemofilie
      http://pageoverview.com/website-report/mijnhemofilie.be
      • Google Analytics: 75999011-1
      Information and Resources for Bleeding Disorders & Hemophilia
      http://pageoverview.com/website-report/bleedingdisorders.com
      Dedicated to helping you understand bleeding disorders and hemophilia, finding support, and offering tips for staying healthy.
      • Expected expiration: August 24th in 2018
      • Creation date: August 24th in 2004
      • Renew date: October 13th in 2016
      • Google Analytics: 73268837-7
      CUVITRU Patient | Home
      http://pageoverview.com/website-report/cuvitru.com
      Learn about CUVITRU, a 20% subcutaneous immunoglobulin replacement therapy for primary humoral immunodeficiency (PI) in adults and children 2 years of age and older.
      • Expected expiration: November 13th in 2018
      • Creation date: November 13th in 2015
      • Renew date: November 9th in 2017
      • Google Analytics: 82959602-1
      CPAMM The Coalition to Prevent ADHD Medication Misuse
      http://pageoverview.com/website-report/cpamm.org
        Shire UK -     Welcome to Shire Pharmaceuticals UK
        http://pageoverview.com/website-report/shirepharmaceuticals.co.uk
        • Renew date: February 8th in 2018
        • Google Analytics: 27662357-1
        FIRAZYR® (icatibant injection)
        http://pageoverview.com/website-report/firazyr.com
        The official website of FIRAZYR® (icatibant injection) by Shire. Learn more about associated risks and benefits, including important safety information.
        • Expected expiration: November 22nd in 2018
        • Creation date: November 22nd in 2005
        • Renew date: October 30th in 2017
        Strongbridge Biopharma
        http://pageoverview.com/website-report/strongbridgebio.com
        Strongbridge.  Driven by passion. Focused on results. See how we’re bridging treatment gaps in rare diseases.
        • Expected expiration: August 25th in 2020
        • Creation date: August 25th in 2015
        • Renew date: September 3rd in 2015
        • Google Analytics: 32676448-27
        0.0584 // 2024-05-03 18:55:51
        All Rights reserved 2018 © PageOverview.com